JPX:4263

SUSMED,Inc. · JPX · Healthcare · JPY · FY for 2026

Figures on this page computed 2026-11-08 13:02 UTC

Last close

n/aJPY

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
-77.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
-110.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
JPY
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
JPY
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.51x

1.58x

2.32x

n/a

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2026

Computed2026

Computed2026

Computed2026

Market datan/a

Each against its own average

3 of 5 read

Except where said otherwise: Computed from the filing for 2026

Sales1.51x
Its own average over 7 years, 328.7M.
Profit1.58x
Its own average over 7 years, -242.5M.
Free cash flow2.32x
Its own average over 7 years, -236.2M.
Debtn/a
Its own average over 0 years.
Pricen/a
Its own average over 0 years. Market data

Free cash flow is furthest from its own average, at 2.32 times.

Sales is 1.51 times its own 7-year average; Profit is 1.58 times its own 7-year average; Free cash flow is 2.32 times its own 7-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales against its own 7-year average1.51
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Profit against its own 7-year average1.58
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Free cash flow against its own 7-year average2.32
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Debt against its own 0-year averagen/a
Not held.
Source
computed
Statement
income
Fiscal year
2026
Reported in
JPY
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
JPY